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ABSTRACT 
Purpose:. The aim was to evaluate the outcome of a short wide body implant in the atrophic 
posterior jaw without grafting procedure. 
Materials and methods:Patients treated with a tapered wide body implant of 8-9 mm width 
and 7-9 mm length (Max® implant, Southern Implants®, Irene, South Africa) were recalled to 
scrutinize implant survival. Preoperative cone beam CT images were analysed to measure 
bone height in reference to the mandibular canal and sinus floor.  
Results: 57 implants were inserted in 18 males and 24 females following a 2-stage procedure 
and delayed loading. The mean follow-up was 15 months (SD 10,range 1-32), with 63.2% of 
the implants having at least 1 year and 26.3% having at least 2 years follow-up.  46 implants 
were inserted in the posterior maxilla and 11 in the mandible. 15 were placed in an extraction 
socket and 42 in healed bone. 13 implants were supporting a single crown.  
2 implants failed, resulting in a survival rate of 96.5%, respectively 90.9% and 97.8% for 
mandible and maxilla. This was not affected by gender, jaw, immediate or delayed 
placement, implant diameter and length or the use of a bone substitutes.   
The mean preoperative bone height was 7.21mm in maxilla and 8.76mm in mandible. In 41 
cases, implant length surpassed available bone height.  
Conclusions: Despite the compromised bone condition and height, the survival of 96.5% is 
comparable to normal implants and an alternative for grafting procedures. This is probably 
related to the enlarged implant surface area and the good primary stability.   
INTRODUCTION 
Good short and long-term results have been reported with dental implants 1, 2, 6. However, the 
posterior maxilla and mandible were considered to be “risk” zones due to the higher occlusal 
forces, inferior bone quality and the often limited amount of bone 49, 67. Additionally, the 
positioning of the maxillary sinus and the mandibular nerve often limits the available bone 
height for implant placement.  
The first generation, turned titanium implants, were depending on their length to achieve 
enhanced stability and sufficient bone-to-implant contact. This was not always possible, 
especially in the posterior jaw and thus short implants were related to an increased failure 
rate. The wide diameter implant was introduced to increase the available contact surface for 
osseointegration and enhanced primary stability 21, 40, 46. Unfortunately, the first results were 
disappointing, reporting failure rates of 9 % to 24% within 5 years 5, 19, 37, 60.  Later studies, 
using an improved implant design with modified implant surface and adapted drilling protocol 
reported less than 5% failures after 5 years 4, 10, 12, 42. 
Short implants are defined as being 10 mm or shorter 22, 31, 47. Their advantage lies in the fact 
that they can be inserted in limited bone height, hereby avoiding sinus lifting, nerve 
repositioning or onlay grafts. This decreases morbidity and complications linked with these 
extra surgical procedures, reduce the total treatment time, lowers the costs and improves the 
patient’s satisfaction 47. However, the initial results when short implants were used were 
rather disappointing with failure rates of 17% to 25% 8, 39, 50, 73. This was explained by the 
lower bone quality of the posterior area 44. The introduction of the moderately rough implants 
increased these survival rates to 95.1% to 100% 10, 31, 51. 
The implant used for this study was the Max® implant (Southern Implants®, Irene, South 
Africa), a wide diameter implant intended for the posterior jaw. Good results have been 
reported for this implant under various conditions 69. The aim of this study was to evaluate 
the outcome of short, wide diameter implants in the posterior area as an alternative for bone 
grafting or sinus lifting.  
 
MATERIALS AND METHODS 
Implant design 
The Max® implants are commercially available in 7, 8, 9, or 10 mm width and 7 - 13 mm 
length, with a 0.8 mm thread pitch (Figure 1). They have an external hex and a moderately 
rough surface created by sandblasting and chemically conditioned with solvents of a grade 4 
commercially pure titanium, with a Sa value of 1.343, 62. Due to the wide diameter, there is a 
platform shifting of 0.25 mm on the horizontal plane and a further 0.35mm when the 45 
degree bevel is included.  
Data collecting and patient selection 
All patients were consecutively treated in the past with at least one short Max® implant (7 to 
9 mm) by one maxillofacial surgeon (AT).  Patients were encouraged to participate in the 
study and asked to attend a clinical examination by an independent multidisciplinary team of 
researchers of the University of Ghent, Belgium. All patients were personally contacted to be 
invited for a clinical examination. Thus, patients were included  depending on their availability 
at the time of the clinical examination by the visiting research team. This study was approved 
by the Ethical Comité of the University Hospital Ghent, Belgium, and was in accordance with 
the Consort statement on clinical research design and the Helsinki statement on medical 
protocols and ethics. 
Implant data were collected from patient files and clinical examination. Parameters were time 
of placement, time of loading, 1 or 2 stage surgery, additional usage of a grafting material , 
implant position and implant dimensions, type of prosthetic reconstruction and gender. 
Delayed placement was defined as  “implant placement at least 6 months after tooth 
extraction”. Pre-operative cone beam CT’s (I-Cat,  Imaging Sciences, Hatfield, PA, USA) 
were analyzed and the available bone height was measured. In the maxilla, the distance 
from the bone crest to the sinusfloor was measured and in the mandible, the distance from 
the crest to the mandibular nerve. 
Statistics were done using PASW  v18. Fisher’s Exact Test was used to compare implant 
survival between groups. The level of significance was set at P = 0.05. 
 
RESULTS 
 Up to the time of examination, 94 implants corresponding to the selection criteria had been 
installed in 84 patients. In total 3 implants had failed, resulting in an overall survival rate of 
96.8%.  
In total, 42 patients (18 males and 24 females), representing 57 implants, presented 
themselves for detailed clinical examination. Mean age was 59 years (SD 13, range 28-84). 
The mean follow-up time was 15 months (SD 10, range 1-32), with 63.2% of the implants 
having at least 1 year follow-up and 26.3% having at least 2 years follow-up.  46 implants 
were inserted in the posterior maxilla and 11 in the mandible (Figure 2). 15 were immediate 
placements in an extraction socket and 42 in healed bone. All implants were placed with a 2 
stage procedure and delayed loaded after 3 to 6 months. Implant dimensions are depicted in 
Table 1. A bone substitute was used around 13 implants (22.8%), of which 3 extraction 
cases.  13 implants were supporting a single crown (22.8%), 35 a fixed partial prosthesis 
(61.4%), 7 a fixed full prosthesis (12.3%) and 2 a full removable prosthesis (3.5%).  
2 out of 57 implants failed, resulting in an overall survival rate of 96,5%, respectively 90.9% 
and 97.8% for mandible and maxilla. The survival rate was not affected by gender (P 
=0,499), jaw (0.352), immediate or healed bone (P = 1.000), implant diameter (P = 1.000), 
implant length (P = 0.119),the use of a bone substitute (Cerasorb®, Curasan AG, 
Kleinostheim, Germany)  (P = 1.000) or the type of prosthetic reconstruction (P=0.220) 
(Table 2). Additionally, there was no significant difference in failure rate between the splinted 
(2.3%) and non-splinted (7.7%) implants (P=0.351). 
In the maxilla the mean preoperative bone height was 7.21 mm (SD 1.78, range 4.30 – 
12.13) for a mean implant length of 8.39 mm (SD 0.93, range 7.00 – 9.00).  In the mandible 
8.76 mm (SD 1.98, range 7.00 – 12.74) bone height was available for a mean 7.91 mm (SD 
1.04, range 7.00 – 9.00) implant length. 
In 41 cases (71.9%), the implant length surpassed the available bone height. 39 were in the 
maxilla and 2 in the mandible. 13 implants had a length of 7 mm, while 28 had a length of 9 
mm (Figure 3).  
 
DISCUSSION 
The current study is based on a cohort of 42 clinically examined patients out of a total group 
of 84 consecutively treated patients. This selection was not biased, but relied on the 
availability of the patients during the time of visit of the external examiners. The study by 
Hermann et al.34 indicates that with this approach, even a 50% drop-out, does not alter the 
outcome. Hence, the outcome of the cohort can be considered representative for the whole 
population. With a 96.5 % surival rate, the outcome of the Max implant is comparable with 
other studies using a similar treatment protocol, reporting survival rates of 73.8% to 100% 4, 5, 
19, 28, 30, 42, 45, 48, 60, 65
. However, some of these include turned implants, which may be 
responsible for some of the lower results. Although only a limited number of 15 implants were 
followed for over 2 years, implant failure occurred only during the first months after surgery, 
suggesting a stable condition over time.   
Although some authors reported better results in the maxilla compared to the mandible 19, 30, 
37, 57
., this was not observed in the current study. The wide diameter of the implants allowed 
good primary stability when placed in molar extraction sites. In this study, no difference was 
found between immediate and delayed placement, which confirms earlier reports in the 
literature 13, 16, 25, 27, 29, 43, 55. Immediate placement can be a predictable procedure if primary 
stability is achieved.  
Neither implant length nor diameter had any effect on implant survival. This confirms the 
conclusion of an extensive review, which found no correlation between implant length or 
diameter, and implant failure 58. Although all implants were shorter than 10 mm, the 96.5% 
survival rate is still better than most other short-implant studies reporting survival of 79.7% to 
100%7, 18, 38, 68 10, 15, 39, 66, 72 31, 51, 61 50 23 33, 36, 73 56 52. This is possibly due to the wide diameter, 
which increases the contact surface.  
However, to be clinically relevant and honest, one should compare the outcome of short/wide 
implants with those implants placed in combination with sinus graft or nerve transposition.  
Implant survival rates in combination with sinus graft range between 84% and 100% 17 20, 32, 
35, 41, 53, 59, 71, 74, 76
 







.Although some studies report results comparable to 
short implants, one should not forget the additional costs and time that goes with sinus 
grafting.  
In the current study, the available bone height was very limited. 41 implants exceeded the 
available bone height in length, which means that these perforated the sinus floor or were 
positioned above the crest. As can be seen in Table 3, the contact surface is still large when 
the implant is placed 2 mm above the crest or 3 mm above the sinus floor. The Max implant 
largely surpasses the contact surface of standard implants. A standard diameter implant 
(Ø3.75mm) with a length of 7 or 13 mm has a maximal contact surface of 95.3 and   193.1 
mm² respectively. Gabbert et al.26 reported no difference when implants were placed in 
normal bone or when implants were placed in limited bone height, without the use of a graft 
material. In 30% of the cases, additional bone formation was observed by lifting the 
membrane alone without the use of a bone substitute. Although it was not the aim of the 
study to perform cone beam evaluations for reasons of radiation protection rules, some 
images were available. On those images, bone formation around the apex of the implant 
when the membrane was lifted was likely to have occurred. (Figure 4). The interpretation of 
these cone beam images remains, however, questionable and further long-term research 
seems mandatory in order to sustain this conclusion.  
The results of the cross sectional study revealed that implants were often inserted in bone 
with limited width. Often the available crest was smaller than the used implant diameter. 
Consequently, the implant was not always completely surrounded by bone and some threads 
were exposed supracrestally. Whether this affects the peri-implant health in the long term 
remains to be investigated. In the meantime, it seems advisable to introduce a diameter 7 
mm implant of the same design to overcome the vast majority of these cases and to facilitate 
inclusion of patients. 
 
CONCLUSION 
Despite the compromised bone condition and height, the survival of 96.5% is comparable to 
normal implants and a good alternative for grafting procedures. This is probably related to 
the enlarged implant surface area, the good primary stability, the moderately rough surface 
and the bicortical anchorage obtained in the maxilla due to lifting of the sinus floor 
membrane. However, more long-term survival studies on a larger patient cohort are 
necessary to sustain this treatment protocol.  
Figure 1: Image of the Max implant 
 
Figure 2: Overview of implant positions 
  
Figure 3: Boxplot representing the pre-operative available bone height and actual 
implant length for the maxilla and mandible. 
 
Figure 4: Cone Beam CT image, pre- and 1 year post-operatively with the restoration in 
place. The sinuslift elevation has stimulated apical bone appositioning. On the other 
hand, buccal bone loss is visible because the original bone width was limited and the 
implant was obviously not completely surrounded with bone.  
 
Table 1: Implant distribution according to implant length and diameter 
 
Implant diameter 
Total 8,0 mm 9,0 mm 
Implant 
length 
7,0 mm 19 1 20 
9,0 mm 30 7 37 
Total  49 8 57 
 
Table 2: The different variables with their corresponding implant number, implant 
survival and P-value 
  # Implants Survival P-Value 
Gender Male 25 100 % 0.499 
 Female 32 93.8 %  
Jaw Maxilla 46 97.8 % 0.352 
 Mandible 11 90.9 %  
Implant length 7 mm 20 90.0 % 0.119 
 9 mm 37 100 %  
Implant diameter 8 mm 49 95.9 % 1.000 
 9 mm 8 100 %  
Time of placement Immediate 15 100 % 1.000 
 Delayed 42 95.2 %  
Bone substitute Yes 13 100 % 1.000 
 No 44 95.5 %  
Type of prosthetic 
reconstruction 
Single crown 13 92.3 % 0.220 
Fixed partial prosthesis 35 100 %  
 Fixed full prosthesis 7 85.7 %  







Table 3: Available contact surface for osseointegration when the implant is fully in the 
bone, 2 mm above the crest or 3 mm into the sinus. 
  
Fully in bone 
   
2mm supra crestal 
   
3mm apically lifting sinusfloor 
  
Implant Area in bone (mm²) Area in bone (mm²) Area in bone (mm²) 
MAX-8-7 224,4 151,5 150,0 
MAX-8-9 282,5 208,4 218,4 
MAX-9-7 258,4 172,3 174,4 
MAX-9-9 326,7 313,1 249,4 
 
1. Adell R, Eriksson B, Lekholm U, Branemark PI, Jemt T. Long-term follow-up study of 
osseointegrated implants in the treatment of totally edentulous jaws. Int J Oral Maxillofac Implants 
1990; 5: 347-359. 
2. Albrektsson T, Sennerby L. Direct bone anchorage of oral implants: clinical and experimental 
considerations of the concept of osseointegration. Int J Prosthodont 1990; 3: 30-41. 
3. Albrektsson T, Wennerberg A. Oral implant surfaces: Part 1--review focusing on topographic 
and chemical properties of different surfaces and in vivo responses to them. Int J Prosthodont 2004; 
17: 536-543. 
4. Anner R, Better H, Chaushu G. The clinical effectiveness of 6 mm diameter implants. J 
Periodontol 2005; 76: 1013-1015. 
5. Attard NJ, Zarb GA. Implant prosthodontic management of partially edentulous patients 
missing posterior teeth: the Toronto experience. J Prosthet Dent 2003; 89: 352-359. 
6. Attard NJ, Zarb GA. Long-term treatment outcomes in edentulous patients with implant-fixed 
prostheses: the Toronto study. Int J Prosthodont 2004; 17: 417-424. 
7. Bahat O. Treatment planning and placement of implants in the posterior maxillae: report of 
732 consecutive Nobelpharma implants. Int J Oral Maxillofac Implants 1993; 8: 151-161. 
8. Bahat O. Branemark system implants in the posterior maxilla: clinical study of 660 implants 
followed for 5 to 12 years. Int J Oral Maxillofac Implants 2000; 15: 646-653. 
9. Bahat O, Fontanessi RV. Efficacy of implant placement after bone grafting for three-
dimensional reconstruction of the posterior jaw. Int J Periodontics Restorative Dent 2001; 21: 220-
231. 
10. Bischof M, Nedir R, Abi Najm S, Szmukler-Moncler S, Samson J. A five-year life-table analysis 
on wide neck ITI implants with prosthetic evaluation and radiographic analysis: results from a private 
practice. Clin Oral Implants Res 2006; 17: 512-520. 
11. Blomqvist JE, Alberius P, Isaksson S. Two-stage maxillary sinus reconstruction with 
endosseous implants: a prospective study. Int J Oral Maxillofac Implants 1998; 13: 758-766. 
12. Bornstein MM, Harnisch H, Lussi A, Buser D. Clinical performance of wide-body implants with 
a sandblasted and acid-etched (SLA) surface: results of a 3-year follow-up study in a referral clinic. Int 
J Oral Maxillofac Implants 2007; 22: 631-638. 
13. Botticelli D, Renzi A, Lindhe J, Berglundh T. Implants in fresh extraction sockets: a prospective 
5-year follow-up clinical study. Clin Oral Implants Res 2008; 19: 1226-1232. 
14. Buchmann R, Khoury F, Faust C, Lange DE. Peri-implant conditions in periodontally 
compromised patients following maxillary sinus augmentation. A long-term post-therapy trial. Clin 
Oral Implants Res 1999; 10: 103-110. 
15. Buser D, Mericske-Stern R, Bernard JP, Behneke A, Behneke N, Hirt HP, Belser UC, Lang NP. 
Long-term evaluation of non-submerged ITI implants. Part 1: 8-year life table analysis of a 
prospective multi-center study with 2359 implants. Clin Oral Implants Res 1997; 8: 161-172. 
16. Cafiero C, Annibali S, Gherlone E, Grassi FR, Gualini F, Magliano A, Romeo E, Tonelli P, Lang 
NP, Salvi GE. Immediate transmucosal implant placement in molar extraction sites: a 12-month 
prospective multicenter cohort study. Clin Oral Implants Res 2008; 19: 476-482. 
17. Chen TW, Chang HS, Leung KW, Lai YL, Kao SY. Implant placement immediately after the 
lateral approach of the trap door window procedure to create a maxillary sinus lift without bone 
grafting: a 2-year retrospective evaluation of 47 implants in 33 patients. J Oral Maxillofac Surg 2007; 
65: 2324-2328. 
18. Corrente G, Abundo R, des Ambrois AB, Savio L, Perelli M. Short porous implants in the 
posterior maxilla: a 3-year report of a prospective study. Int J Periodontics Restorative Dent 2009; 29: 
23-29. 
19. Eckert SE, Meraw SJ, Weaver AL, Lohse CM. Early experience with Wide-Platform Mk II 
implants. Part I: Implant survival. Part II: Evaluation of risk factors involving implant survival. Int J Oral 
Maxillofac Implants 2001; 16: 208-216. 
20. Engelke W, Schwarzwaller W, Behnsen A, Jacobs HG. Subantroscopic laterobasal sinus floor 
augmentation (SALSA): an up-to-5-year clinical study. Int J Oral Maxillofac Implants 2003; 18: 135-
143. 
21. Ettinger RL, Spivey JD, Han DH, Koorbusch GF. Measurement of the interface between bone 
and immediate endosseous implants: a pilot study in dogs. Int J Oral Maxillofac Implants 1993; 8: 
420-427. 
22. Feldman S, Boitel N, Weng D, Kohles SS, Stach RM. Five-year survival distributions of short-
length (10 mm or less) machined-surfaced and Osseotite implants. Clin Implant Dent Relat Res 2004; 
6: 16-23. 
23. Friberg B, Grondahl K, Lekholm U, Branemark PI. Long-term follow-up of severely atrophic 
edentulous mandibles reconstructed with short Branemark implants. Clin Implant Dent Relat Res 
2000; 2: 184-189. 
24. Froum SJ, Tarnow DP, Wallace SS, Rohrer MD, Cho SC. Sinus floor elevation using anorganic 
bovine bone matrix (OsteoGraf/N) with and without autogenous bone: a clinical, histologic, 
radiographic, and histomorphometric analysis--Part 2 of an ongoing prospective study. Int J 
Periodontics Restorative Dent 1998; 18: 528-543. 
25. Fugazzotto PA. Implant placement at the time of maxillary molar extraction: treatment 
protocols and report of results. J Periodontol 2008; 79: 216-223. 
26. Gabbert O, Koob A, Schmitter M, Rammelsberg P. Implants placed in combination with an 
internal sinus lift without graft material: an analysis of short-term failure. J Clin Periodontol 2009; 36: 
177-183. 
27. Gelb DA. Immediate implant surgery: three-year retrospective evaluation of 50 consecutive 
cases. Int J Oral Maxillofac Implants 1993; 8: 388-399. 
28. Gentile MA, Chuang SK, Dodson TB. Survival estimates and risk factors for failure with 6 x 5.7-
mm implants. Int J Oral Maxillofac Implants 2005; 20: 930-937. 
29. Gomez-Roman G, Kruppenbacher M, Weber H, Schulte W. Immediate postextraction implant 
placement with root-analog stepped implants: surgical procedure and statistical outcome after 6 
years. Int J Oral Maxillofac Implants 2001; 16: 503-513. 
30. Graves SL, Jansen CE, Siddiqui AA, Beaty KD. Wide diameter implants: indications, 
considerations and preliminary results over a two-year period. Aust Prosthodont J 1994; 8: 31-37. 
31. Griffin TJ, Cheung WS. The use of short, wide implants in posterior areas with reduced bone 
height: a retrospective investigation. J Prosthet Dent 2004; 92: 139-144. 
32. Hallman M, Sennerby L, Lundgren S. A clinical and histologic evaluation of implant integration 
in the posterior maxilla after sinus floor augmentation with autogenous bone, bovine hydroxyapatite, 
or a 20:80 mixture. Int J Oral Maxillofac Implants 2002; 17: 635-643. 
33. Herrmann I, Lekholm U, Holm S, Kultje C. Evaluation of patient and implant characteristics as 
potential prognostic factors for oral implant failures. Int J Oral Maxillofac Implants 2005; 20: 220-230. 
34. Herrrmann I, Lekholm U, Holm S. Statistical outcome of random versus selected withdrawal 
of dental implants. Int J Prosthodont 2003; 16: 25-30. 
35. Hurzeler MB, Kirsch A, Ackermann KL, Quinones CR. Reconstruction of the severely resorbed 
maxilla with dental implants in the augmented maxillary sinus: a 5-year clinical investigation. Int J 
Oral Maxillofac Implants 1996; 11: 466-475. 
36. Ibanez JC, Tahhan MJ, Zamar JA. Performance of double acid-etched surface external hex 
titanium implants in relation to one- and two-stage surgical procedures. J Periodontol 2003; 74: 
1575-1581. 
37. Ivanoff CJ, Grondahl K, Sennerby L, Bergstrom C, Lekholm U. Influence of variations in 
implant diameters: a 3- to 5-year retrospective clinical report. Int J Oral Maxillofac Implants 1999; 14: 
173-180. 
38. Jemt T. Failures and complications in 391 consecutively inserted fixed prostheses supported 
by Branemark implants in edentulous jaws: a study of treatment from the time of prosthesis 
placement to the first annual checkup. Int J Oral Maxillofac Implants 1991; 6: 270-276. 
39. Jemt T, Lekholm U. Implant treatment in edentulous maxillae: a 5-year follow-up report on 
patients with different degrees of jaw resorption. Int J Oral Maxillofac Implants 1995; 10: 303-311. 
40. Kohn DH. Overview of factors important in implant design. J Oral Implantol 1992; 18: 204-
219. 
41. Krennmair G, Krainhofner M, Schmid-Schwap M, Piehslinger E. Maxillary sinus lift for single 
implant-supported restorations: a clinical study. Int J Oral Maxillofac Implants 2007; 22: 351-358. 
42. Krennmair G, Waldenberger O. Clinical analysis of wide-diameter frialit-2 implants. Int J Oral 
Maxillofac Implants 2004; 19: 710-715. 
43. Krump JL, Barnett BG. The immediate implant: a treatment alternative. Int J Oral Maxillofac 
Implants 1991; 6: 19-23. 
44. Levin L, Laviv A, Schwartz-Arad D. Long-term success of implants replacing a single molar. J 
Periodontol 2006; 77: 1528-1532. 
45. Levine RA, Ganeles J, Jaffin RA, Clem DS, 3rd, Beagle JR, Keller GW. Multicenter retrospective 
analysis of wide-neck dental implants for single molar replacement. Int J Oral Maxillofac Implants 
2007; 22: 736-742. 
46. Misch CE. Implant design considerations for the posterior regions of the mouth. Implant Dent 
1999; 8: 376-386. 
47. Morand M, Irinakis T. The challenge of implant therapy in the posterior maxilla: providing a 
rationale for the use of short implants. J Oral Implantol 2007; 33: 257-266. 
48. Mordenfeld MH, Johansson A, Hedin M, Billstrom C, Fyrberg KA. A retrospective clinical study 
of wide-diameter implants used in posterior edentulous areas. Int J Oral Maxillofac Implants 2004; 
19: 387-392. 
49. Muftu A, Chapman RJ. Replacing posterior teeth with freestanding implants: four-year 
prosthodontic results of a prospective study. J Am Dent Assoc 1998; 129: 1097-1102. 
50. Naert I, Koutsikakis G, Duyck J, Quirynen M, Jacobs R, van Steenberghe D. Biologic outcome 
of implant-supported restorations in the treatment of partial edentulism. part I: a longitudinal clinical 
evaluation. Clin Oral Implants Res 2002; 13: 381-389. 
51. Nedir R, Bischof M, Briaux JM, Beyer S, Szmukler-Moncler S, Bernard JP. A 7-year life table 
analysis from a prospective study on ITI implants with special emphasis on the use of short implants. 
Results from a private practice. Clin Oral Implants Res 2004; 15: 150-157. 
52. Olate S, Lyrio MC, de Moraes M, Mazzonetto R, Moreira RW. Influence of diameter and 
length of implant on early dental implant failure. J Oral Maxillofac Surg; 68: 414-419. 
53. Olson JW, Dent CD, Morris HF, Ochi S. Long-term assessment (5 to 71 months) of endosseous 
dental implants placed in the augmented maxillary sinus. Ann Periodontol 2000; 5: 152-156. 
54. Peleg M, Mazor Z, Chaushu G, Garg AK. Sinus floor augmentation with simultaneous implant 
placement in the severely atrophic maxilla. J Periodontol 1998; 69: 1397-1403. 
55. Penarrocha-Diago M, Carrillo-Garcia C, Boronat-Lopez A, Garcia-Mira B. Comparative study of 
wide-diameter implants placed after dental extraction and implants positioned in mature bone for 
molar replacement. Int J Oral Maxillofac Implants 2008; 23: 497-501. 
56. Pjetursson BE, Rast C, Bragger U, Schmidlin K, Zwahlen M, Lang NP. Maxillary sinus floor 
elevation using the (transalveolar) osteotome technique with or without grafting material. Part I: 
Implant survival and patients' perception. Clin Oral Implants Res 2009; 20: 667-676. 
57. Polizzi G, Grunder U, Goene R, Hatano N, Henry P, Jackson WJ, Kawamura K, Renouard F, 
Rosenberg R, Triplett G, Werbitt M, Lithner B. Immediate and delayed implant placement into 
extraction sockets: a 5-year report. Clin Implant Dent Relat Res 2000; 2: 93-99. 
58. Renouard F, Nisand D. Impact of implant length and diameter on survival rates. Clin Oral 
Implants Res 2006; 17 Suppl 2: 35-51. 
59. Rodoni LR, Glauser R, Feloutzis A, Hammerle CH. Implants in the posterior maxilla: a 
comparative clinical and radiologic study. Int J Oral Maxillofac Implants 2005; 20: 231-237. 
60. Shin SW, Bryant SR, Zarb GA. A retrospective study on the treatment outcome of wide-
bodied implants. Int J Prosthodont 2004; 17: 52-58. 
61. Stellingsma C, Meijer HJ, Raghoebar GM. Use of short endosseous implants and an 
overdenture in the extremely resorbed mandible: a five-year retrospective study. J Oral Maxillofac 
Surg 2000; 58: 382-387; discussion 387-388. 
62. Svanborg LM, Andersson M, Wennerberg A. Surface characterization of commercial oral 
implants on the nanometer level. J Biomed Mater Res B Appl Biomater 2010; 92: 462-469. 
63. Tarnow DP, Wallace SS, Froum SJ, Rohrer MD, Cho SC. Histologic and clinical comparison of 
bilateral sinus floor elevations with and without barrier membrane placement in 12 patients: Part 3 
of an ongoing prospective study. Int J Periodontics Restorative Dent 2000; 20: 117-125. 
64. Tawil G, Mawla M. Sinus floor elevation using a bovine bone mineral (Bio-Oss) with or 
without the concomitant use of a bilayered collagen barrier (Bio-Gide): a clinical report of immediate 
and delayed implant placement. Int J Oral Maxillofac Implants 2001; 16: 713-721. 
65. Tawil G, Mawla M, Gottlow J. Clinical and radiographic evaluation of the 5-mm diameter 
regular-platform Branemark fixture: 2- to 5-year follow-up. Clin Implant Dent Relat Res 2002; 4: 16-
26. 
66. ten Bruggenkate CM, Asikainen P, Foitzik C, Krekeler G, Sutter F. Short (6-mm) 
nonsubmerged dental implants: results of a Multicenter clinical trial of 1 to 7 years. Int J Oral 
Maxillofac Implants 1998; 13: 791-798. 
67. Truhlar RS, Orenstein IH, Morris HF, Ochi S. Distribution of bone quality in patients receiving 
endosseous dental implants. J Oral Maxillofac Surg 1997; 55: 38-45. 
68. van Steenberghe D, Lekholm U, Bolender C, Folmer T, Henry P, Herrmann I, Higuchi K, Laney 
W, Linden U, Astrand P. Applicability of osseointegrated oral implants in the rehabilitation of partial 
edentulism: a prospective multicenter study on 558 fixtures. Int J Oral Maxillofac Implants 1990; 5: 
272-281. 
69. Vandeweghe S, Ackermann A, Bronner J, Hattingh A, Tschakaloff A, De Bruyn H. A 
Retrospective, Multicenter Study on a Novo Wide-Body Implant for Posterior Regions. Clin Implant 
Dent Relat Res 2009. 
70. Wannfors K, Johansson B, Hallman M, Strandkvist T. A prospective randomized study of 1- 
and 2-stage sinus inlay bone grafts: 1-year follow-up. Int J Oral Maxillofac Implants 2000; 15: 625-
632. 
71. Wiltfang J, Schultze-Mosgau S, Nkenke E, Thorwarth M, Neukam FW, Schlegel KA. Onlay 
augmentation versus sinuslift procedure in the treatment of the severely resorbed maxilla: a 5-year 
comparative longitudinal study. Int J Oral Maxillofac Surg 2005; 34: 885-889. 
72. Winkler S, Morris HF, Ochi S. Implant survival to 36 months as related to length and 
diameter. Ann Periodontol 2000; 5: 22-31. 
73. Wyatt CC, Zarb GA. Treatment outcomes of patients with implant-supported fixed partial 
prostheses. Int J Oral Maxillofac Implants 1998; 13: 204-211. 
74. Zijderveld SA, Zerbo IR, van den Bergh JP, Schulten EA, ten Bruggenkate CM. Maxillary sinus 
floor augmentation using a beta-tricalcium phosphate (Cerasorb) alone compared to autogenous 
bone grafts. Int J Oral Maxillofac Implants 2005; 20: 432-440. 
75. Zinner ID, Small SA. Sinus-lift graft: using the maxillary sinuses to support implants. J Am Dent 
Assoc 1996; 127: 51-57. 
76. Zitzmann NU, Scharer P. Sinus elevation procedures in the resorbed posterior maxilla. 
Comparison of the crestal and lateral approaches. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 
1998; 85: 8-17. 
 
 
